{"created":"2015-05-07T12:00:08+00:00","modified":"2015-05-14T15:18:25+00:00","valid":{"from":"2015-05-07T10:00:00+00:00","to":"3015-05-07T10:00:00+00:00"},"hreflang":"en","byline":"Gigi Douban, Sam Beard, Luke Quinton and Matt Nesto","itags":["Marketplace Morning Report for Thursday, May 7, 2015","PMP:Marketplace_PMP","Marketplace","Marketplace Morning Report","a69a618f16c35f19e64ef72994fa192c"],"title":"Marketplace Morning Report for Thursday, May 7, 2015","teaser":"Airing on Thursday, May 6, 2015: First up, we check the pressure in the global stock market.&nbsp;<span>Alexion—a biotech company with a single drug company— is buying Synageva, a biotech company with a single drug on the market. Yet, they’re two of many biotech companies that are betting on a business in which they develop a drug for a rare disease and charge a ton for it.&nbsp;</span><span>Next, &nbsp;v</span><span>oters go to the polls in a general election in Britain today. Inequality has been a key theme of the campaign. It has been getting some traction from one policy in particular: a plan to close a tax loophole.&nbsp;</span>\n\n&nbsp;\n\n<span>&nbsp;</span>","description":"Airing on Thursday, May 6, 2015: First up, we check the pressure in the global stock market.&nbsp;<span>Alexion—a biotech company with a single drug company— is buying Synageva, a biotech company with a single drug on the market. Yet, they’re two of many biotech companies that are betting on a business in which they develop a drug for a rare disease and charge a ton for it.&nbsp;</span><span>Next, &nbsp;v</span><span>oters go to the polls in a general election in Britain today. Inequality has been a key theme of the campaign. It has been getting some traction from one policy in particular: a plan to close a tax loophole.&nbsp;</span>\n\n&nbsp;\n\n<span>&nbsp;</span>","contentencoded":"<div class=\"barn-cleaned\"></div>","tags":["APM","APM_Episode"],"guid":"a69a618f-16c3-45f1-8e64-f72994fa192c","published":"2015-05-07T10:00:00+00:00","contenttemplated":"[]","audio":[{"href":"http://www.marketplace.org/sites/default/files/styles/primary-image-610x340/public/WWW/data/images/repository/2006/06/27/20060627_biotech_57271221_18.jpg?itok=bNBAOr2k","type":"image/jpeg","meta":{"crop":"primary","width":"610","height":"340"}},{"meta":{"api":{"type":"application/json","href":"http://api.publicradio.org/audio/v2?ref=pmp&id=apm-audio:/marketplace/morning_report/2015/05/07/mmr_20150507_pod"},"duration":400,"duration_hms":"00:06:40"},"format":"MP3","type":"audio/mpeg","href":"http://play.publicradio.org/pmp/d/podcast/marketplace/morning_report/2015/05/07/mmr_20150507_pod_64.mp3"}]}